Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-24 10:33 am Sale | 2021-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Empery Asset Management, LP | 1,484 4.050% | -929 (-38.50%) | Filing History |
| 2021-08-20 4:45 pm Purchase | 2021-08-11 | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Lind Global Fund II LP | 1,302,933 9.900% | 1,302,933 (New Position) | Filing History |
| 2021-08-20 4:40 pm Sale | 2021-08-09 | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Empery Asset Management, LP | 868,622 6.880% | -713,758 (-45.11%) | Filing History |
| 2021-08-19 4:30 pm Purchase | 2021-08-09 | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | BIGGER CAPITAL FUND L P | 797,213 6.300% | 797,213 (New Position) | Filing History |
| 2021-08-18 4:17 pm Sale | 2021-08-09 | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Mitchell P. Kopin | 460,978 3.500% | -1,101,522 (-70.50%) | Filing History |
| 2021-08-17 4:45 pm Purchase | 2021-08-11 | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Lind Global Macro Fund LP | 1,302,933 9.900% | 1,302,933 (New Position) | Filing History |